Skip to main content
Log in

The hormonal regulation of platelet-activating factor acetylhydrolase activity in plasma

  • PAF Metabolism and Its Regulation
  • Published:
Lipids

Abstract

We have previously reported that certain fetal tissues including the lung and kidney have an increased platelet-activating factor (PAF) content and enzymatic mechanism for its elevated biosynthesis during the latter stages of pregnancy. In contrast, in the maternal plasma compartment of both the rabbit and human, a decreased capacity to inactivate PAF has been demonstrated. The PAF acetylhydrolase in the fetal plasma is also suppressed. The present study was undertaken to determine the mechanism(s) involved in the regulation of PAF acetylhydrolase. The 17α-ethynylestradiol was administered (intraperitoneal [i.p.] 2.5 mg/kg body wt 5 days) to female and male rats. The plasma PAF acetylhydrolase activity decreased 5-fold. A decrease was observed when a concentration of the estrogen as low as 50 μg/kg was employed. The injection of dexamethasone (i.p., 1.3 mg/kg body wt, 5 days) to male and female rats resulted in a 3-fold increase in the plasma PAF acetylhydrolase activity. The activity returned to the values prior to hormone treatment 4 days after cessation of treatment. Testosterone and progesterone were without effect on plasma acetylhydrolase activity. The change in PAF acetylhydrolase activity caused by estrogen and the glucocorticoid was reflected by a change in the activity in the HDL fraction and not due to the presence of an inhibitor or activator in the plasma of the hormone-treated animals. Human serum obtained from a group of women, in which the 17β-estradiol concentration was elevated in preparation for anin vitro fertilization procedure, showed an inverse relationship between the plasma estrogen concentration and the PAF acetylhydrolase activity. It is suggested that estrogen is responsible for the regulation of PAF acetylhydrolase and the decrease in the plasma PAF acetylhydrolase during the latter stages of pregnancy in both the maternal and fetal plasma caused by the hyperestrogenic state that occurs during this period. The observed increase in PAF acetylhydrolase by dexamethasone may account for, in part, the known anti-inflammatory properties of this steroid by decreasing the concentration of this potent autacoid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

PAF:

platelet-activating factor

References

  1. Benveniste, J., Henson, P.M., and Cochran, C.C.G. (1972)J. Exp. Med. 136, 1356–1377.

    Article  PubMed  CAS  Google Scholar 

  2. Demopoulos, C.A., Pinckard, R.N., and Hanahan, D.J. (1979)J. Biol. Chem. 154, 9355–9358.

    Google Scholar 

  3. Benveniste, J., Tence, M., Varenne, P., Bidault, J., Boullet, C., and Polonsky, J. (1979)C.R.C. Acad. Sci. Paris. (ser. D) 289, 1037–1040.

    CAS  Google Scholar 

  4. Blank, M.L., Snyder, F., Byers, L.W., Brooks, B., and Muirhead, E.E. (1979)Biochem. Biophys. Res. Commun. 90, 1194–1200.

    PubMed  CAS  Google Scholar 

  5. Hanahan, D.J. (1986)Ann. Rev. Biochem. 55, 483–509.

    Article  PubMed  CAS  Google Scholar 

  6. Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, T.B. (1987)Pharmacol. Rev. 39, 97–145.

    PubMed  CAS  Google Scholar 

  7. Snyder, F. (1989)Proc. Soc. Exp. Biol. Med. 190, 125–135.

    PubMed  CAS  Google Scholar 

  8. O'Flaherty, J.T., Wykle, R.L., Miller, C.H., Lewis, J.C., Waite, M., Bass, D.A., McCall, C.E., and DeChatelet, L.R. (1981)Am. J. Pathol. 103, 70–78.

    PubMed  Google Scholar 

  9. Wardlow, A.J., Moqbel, R., Cromwell, O., and Kay, A.B. (1986)J. Clin. Invest. 78, 1701–1706.

    Google Scholar 

  10. Tamura, N., Agrawal, D.K., Suliaman, F.A., and Townley, R.G. (1987)Biochem. Biophys. Res. Commun. 142, 638–644.

    Article  PubMed  CAS  Google Scholar 

  11. Humphrey, D.M., Hanahan, D.J., and Pinckard, R.N. (1982)Lab. Invest. 47, 227–234.

    PubMed  CAS  Google Scholar 

  12. Humphrey, D.M., McManus, L.M., Satouchi, K., Hanahan, D.J., and Pinckard, R.N. (1982)Lab. Invest. 46, 422–427.

    PubMed  CAS  Google Scholar 

  13. Humphrey, D.M., McManus, L.M., Hanahan, D.J., and Pinckard, R.N. (1984)Lab. Invest. 50, 16–25.

    PubMed  CAS  Google Scholar 

  14. O'Neill, C. (1984) inPlatelet-Activating Factor and Human Diseases (Barnes, P.J., Page, C.P., and Henson, P.M., eds.) Blackwell Scientific Publications, Oxford, United Kingdom, pp. 282–296.

    Google Scholar 

  15. Johnston, J.M., and Maki, N. (1989) inPlatelet-Activating Factor and Human Diseases (Barnes, P.J., Page, C.P., and Henson, P.M., eds.) Blackwell Scientific Publications, Oxford, United Kingdom, pp. 297–323.

    Google Scholar 

  16. Abisogun, A.O., Braquet, P., and Tsafriri, A. (1989)Science 243, 381–383.

    Article  PubMed  CAS  Google Scholar 

  17. Kumar, R., Harper, M.J.K., and Hanahan, D. (1988)Arch. Biochem. Biophys. 260, 497–502.

    Article  PubMed  CAS  Google Scholar 

  18. Lee, T.-C., and Snyder, F. (1989) inPlatelet-Activating Factor and Human Diseases (Barnes, P.J., Page, C.P., and Henson, P.M., eds.) Blackwell Scientific Publications, Oxford, United Kingdom, pp. 1–22.

    Google Scholar 

  19. Lenihan, D.J., Greenberg, N., and Lee, T.-C. (1985)Comp. Biochem. Physiol. 81C, 81–86.

    CAS  Google Scholar 

  20. Suzuki, Y., Miwa, M., Harada, M., and Matsumoto, M. (1988)Eur. J. Biochem. 712, 117–120.

    Article  Google Scholar 

  21. Satoh, K., Imaizumi, T.-A., Kawamura, Y., Yoshida, H., Takamatsu, S., and Mizono, S. (1988)Prostaglandins 35, 685–698.

    Article  PubMed  CAS  Google Scholar 

  22. Maki, N., Hoffman, D.R., and Johnston, J.M. (1988)Proc. Natl. Acad. Sci. USA 85, 728–732.

    Article  PubMed  CAS  Google Scholar 

  23. Johnston, J.M. (1989) inPlatelet-Activating Factor and Diseases (Saito, K., and Hanahan, D.J., eds.) International Medical Publishers, Tokyo, Japan, pp. 129–152.

    Google Scholar 

  24. Miwa, M., Miyake, T., Yamanaka, T., Sugatani, J., Suzuki, Y., Sakata, S., Araki, Y., and Matsumoto, M. (1988)J. Clin. Invest. 82, 1983–1991.

    PubMed  CAS  Google Scholar 

  25. Hofmann, B., Ruhling, K., Spangenberg, P., and Ostermann, G. (1989)Haemostasis 19, 180–184.

    PubMed  CAS  Google Scholar 

  26. Blank, M.L., Hall, M.N., Cress, E.A., and Snyder, F. (1983)Biochem. Biophys. Res. Commun. 113, 666–671.

    Article  PubMed  CAS  Google Scholar 

  27. Crook, J.E., Mroczkowski, P.J., Cress, E.A., Blank, M.L., and Snyder, F. (1988)Clin. Sci. 74, 393–396.

    Google Scholar 

  28. Elstad, M.R., Stafforini, D.M., Stremler, K.E., Zimmerman, G.A., McIntyre, M., and Prescott, S.M. (1989) inPlatelet-Activating Factor and Diseases (Saito, K., and Hanahan, D.J., eds.) International Medical Publishers, Tokyo, Japan, pp. 29–84.

    Google Scholar 

  29. Havel, R.J., Eber, H.A., and Bragdom, J.H. (1955)J. Clin. Invest. 34, 1345–1353.

    PubMed  CAS  Google Scholar 

  30. Pritchard, P.H. (1987)Biochem. J. 246, 791–794.

    PubMed  CAS  Google Scholar 

  31. Blank, M.L., Lee, T.-C., Fitzgerald, V., and Snyder, F. (1981)J. Biol. Chem. 251, 175–178.

    Google Scholar 

  32. Farr, R.S., Cox, C.P., Wardlow, M.L., and Jorgensen, R. (1980)Clin. Immunol. Immunopathol. 15, 318–330.

    Article  PubMed  CAS  Google Scholar 

  33. Farr, R.S., Wardlow, M.L., Cox, C.P., Meng, K.E., and Greene, D.E. (1983)Fed. Proc. 42, 3120–3122.

    PubMed  CAS  Google Scholar 

  34. Harper, M.J.K. (1989)Biol. Reprod. 40, 907–913.

    Article  PubMed  CAS  Google Scholar 

  35. Billah, M.M., and Johnston, J.M. (1983)Biochem. Biophys. Res. Commun. 113, 51–58.

    Article  PubMed  CAS  Google Scholar 

  36. Nishihara, J., Ishibashi, T., Imai, Y., and Muramatsu, T. (1984)Lipids 19, 907–910.

    Article  Google Scholar 

  37. Hoffman, D.R., Romero, R., and Johnston, J.M. (1990)Am. J. Obstet. Gynecol. 162, 525–528.

    PubMed  CAS  Google Scholar 

  38. Hoffman, D.R., Truong, C.T., and Johnston, J.M. (1986)Biochim. Biophys. Acta 879, 88–96.

    PubMed  CAS  Google Scholar 

  39. Billah, M.M., Di Renzo, G.C., Ban, C., Truong, C.T., Hoffman, D.R., Anceschi, M.M., Bleasdale, J.E., and Johnston, J.M. (1985)Prostaglandins 30, 841–850.

    Article  PubMed  CAS  Google Scholar 

  40. Bleasdale, J.E., Bala, G.A., Thakur, N.R., McGuire, J.C., and Di Renzo, G.C. (1989) inProceedings of XI European Congress of Perinatal Medicine, Harwood Academic Publishers, Switzerland, pp. 828–834.

    Google Scholar 

  41. Montrucchio, G., Alloatti, G., Tetta, C., Roffinello, C., Emanuelli, G., and Camussi, G. (1986)Prostaglandins 32, 539–554.

    Article  PubMed  CAS  Google Scholar 

  42. Tetta, G., Montrucchio, G., Alloatti, G., Roffinello, C., Emanuellelli, G., Benedetto, C., Camussi, G., and Massobrio, M. (1986)Proc. Soc. Exp. Biol. Med. 183, 376–381.

    PubMed  CAS  Google Scholar 

  43. Zhu, Y.-P., Word, R.A., and Johnston, J.M. (1990)Proc. Soc. Gynecol. Invest., abstract, No. 130, p. 161.

    Google Scholar 

  44. Zhu, Y.-P., Hoffman, D.R., Hwang, S.-B., Miyaura, S., and Johnston, J.M. (1991)Biol. Reprod. 44, 39–42.

    Article  PubMed  CAS  Google Scholar 

  45. Angle, M.J., Pinckard, R.N., Showell, H.J., and McManus, L.M. (1987)Lab. Invest. 57, 321–328.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Miyaura, S., Maki, N., Byrd, W. et al. The hormonal regulation of platelet-activating factor acetylhydrolase activity in plasma. Lipids 26, 1015–1020 (1991). https://doi.org/10.1007/BF02536494

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02536494

Keywords

Navigation